Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

被引：0
|
作者：
Greg W Mattingly
Richard H Weisler
Joel Young
Ben Adeyi
Bryan Dirks
Thomas Babcock
Robert Lasser
Brian Scheckner
David W Goodman
机构：
[1] St Charles Psychiatric Associates/Midwest Research,Duke University Medical Center
[2] 4801 Weldon Spring Pkwy,undefined
[3] Durham,undefined
[4] NC,undefined
[5] and University of North Carolina at Chapel Hill,undefined
[6] Rochester Center for Behavioral Medicine,undefined
[7] Shire Development LLC,undefined
[8] Formerly of Shire Development LLC,undefined
[9] Johns Hopkins University School of Medicine,undefined
来源：
BMC Psychiatry | / 13卷
关键词：
Lisdexamfetamine dimesylate (LDX); Attention-deficit/hyperactivity disorder (ADHD); Adults; Response; Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Mattingly, Greg W.
    Weisler, Richard H.
    Young, Joel
    Adeyi, Ben
    Dirks, Bryan
    Babcock, Thomas
    Lasser, Robert
    Scheckner, Brian
    Goodman, David W.
    BMC PSYCHIATRY, 2013, 13
  • [2] Clinical Response and Symptomatic Remission in Children Treated With Lisdexamfetamine Dimesylate for Attention-Deficit/Hyperactivity Disorder
    Findling, Robert L.
    Adeyi, Ben
    Chen, Gary
    Dirks, Bryan
    Babcock, Thomas
    Scheckner, Brian
    Lasser, Robert
    Pucci, Michael L.
    Abdullah, Huda I.
    McGough, James J.
    CNS SPECTRUMS, 2010, 15 (09) : 559 - 568
  • [3] Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
    Weisler, Richard
    Young, Joel
    Mattingly, Greg
    Gao, Joseph
    Squires, Liza
    Adler, Lenard
    CNS SPECTRUMS, 2009, 14 (10) : 573 - 585
  • [4] Long-term safety and efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Lasser, R.
    Weisler, R.
    Young, J.
    Mattingly, G.
    Gao, J.
    Adler, L.
    Squires, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S356 - S356
  • [5] Lisdexamfetamine Dimesylate In Attention-Deficit Hyperactivity Disorder in Adults
    Weber, Juliane
    Siddiqui, M. Asif A.
    CNS DRUGS, 2009, 23 (05) : 419 - 425
  • [6] Long-term safety of lisdexamfetamine dimesylate (LDX) in adolescents with attention-deficit/hyperactivity disorder
    Findling, R.
    Childress, A.
    Cutler, A.
    Hamdani, M.
    Ferreira-Cornwell, M. C.
    Shaw, M.
    Gasior, M.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S117 - S118
  • [7] Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity
    Ginsberg, Lawrence
    Katic, Alain
    Adeyi, Ben
    Dirks, Bryan
    Babcock, Thomas
    Lasser, Robert
    Scheckner, Brian
    Adler, Lenard A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (06) : 1097 - 1107
  • [8] Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder
    Wigal, Timothy
    Brams, Matthew
    Gasior, Maria
    Gao, Joseph
    Giblin, John
    POSTGRADUATE MEDICINE, 2011, 123 (02) : 169 - 176
  • [9] Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder
    Lenard A Adler
    David Goodman
    Richard Weisler
    Mohamed Hamdani
    Thomas Roth
    Behavioral and Brain Functions, 5
  • [10] Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorder
    Adler, Lenard A.
    Goodman, David
    Weisler, Richard
    Hamdani, Mohamed
    Roth, Thomas
    BEHAVIORAL AND BRAIN FUNCTIONS, 2009, 5
12345